Apple Watch Series 12 is tipped for a 2026 release with an all-new eight-sensor ring on the back, visible through a glass cover and doubling the sensor count from current models. The eight-sensor redesign is expected to dramatically improve health-tracking accuracy by gathering more data points and reducing reliance on guessing by algorithms. Blood pressure…
Read more
Most credible rumors expect a 2025 launch for AirPods Pro 3, with some analysts like Jeff Pu predicting a 2026 release. Launch price is expected to remain around $249, the same as AirPods Pro 2. AirPods Pro 3 will feature a refreshed design with smaller earbuds, a shorter stem, a slimmer case, and a charging-case…
Read more
Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for hospital-grade remote monitoring, enabling cuffless measurement of blood pressure, heart rate, SpO2, and respiratory rate via PPG and AI. On June 19, PharmaSens and SiBionics announced niia™ signature, an all-in-one patch that combines a continuous glucose monitor with an insulin pump, unveiled at ADA…
Read more
Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began a Phase I/II study in 2024, with initial first-in-human data expected in late 2025. Wave…
Read more
Global consumer tech sales are projected to reach $1.29 trillion in 2025, about 2% growth over 2024. Apple leads wearables with roughly a 20–25% global market share in recent quarters, driven by its Watch and AirPods lines. Wearable shipments grew 5.4% in 2024 to 534.6 million units and are expected to grow 4.1% in 2025…
Read more
